Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Atreca, Inc.
3123
Atreca, Inc.
Technology
Biotechnology
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics.
Suggest edits
Founded
2011
Raised
$308.8M
Follow us
Also headquartered in Redwood City
Oracle
Evernote
Electronic Arts
Impossible Foods
Equinix
Carbon
AltspaceVR
Banjo
Talend
C3 IoT
Companies in the same industry
QUIBIM S.L.
Sitka Biopharma
GEN1 Biotechnology
ViraCyte
Pherecydes Pharma
BridgeBio
Enlivex Therapeutics
LabGenius
Symphony Dynamo
Biophytis
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$113,800,000
IPO - 2019
$125,000,000
Venture capital (Series C) - 2018
Redmile Group
Aisling Capital
EcoR1 Capital
+5
Team Size
10+
Employees
I work here
Location
Redwood City
,
United States
Headquarters
Explore Redwood City
$113,800,000
IPO
PE HUB
Biopharma firm Atreca goes public
$125,000,000
Venture capital (Series C)
FinSMEs
,
PE HUB
,
MedCity News
Atreca Raises $125M in Series C Funding
Funding
$35,000,000
Venture capital (Series B)
PE HUB
,
PE HUB
Atreca raises $35 mln Series B co-led by Wellington
Funding
